首页> 外文期刊>European Journal of Pharmacology: An International Journal >Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels.
【24h】

Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels.

机译:肾上腺髓质素与大鼠内源性血管舒张剂协同相互作用:K(ATP)通道的可能作用。

获取原文
获取原文并翻译 | 示例
           

摘要

To examine synergistic interactions among naturally occurring vasodilators, we investigated the effects of i.v. infusion of adrenomedullin (ADM) alone and in combination with low-dose vasoactive intestinal polypeptide (VIP) or calcitonin gene-related peptide (CGRP) on adenosine-induced vasodepression in rats. I.v. infusion of the combination of low-dose ADM (0.1 ng kg(-1) min(-1)) and VIP (3 ng kg(-1) min(-1)), as well as that of ADM (1 ng kg(-1) min(-1)) alone, significantly enhanced the vasodepressor responses to bolus i.v. doses of adenosine (3-100 microg kg(-1)), but not those to acetylcholine (0.1 microg kg(-1)). The observed potentiation did not occur in the presence of glibenclamide (20 mg kg(-1) i.v.), an antagonist of K(ATP) channels. Simultaneous i.v. infusion of low-dose ADM and CGRP (0.1 ng kg(-1) min(-1)) failed to enhance the effects of adenosine as well as acetylcholine. In the whole-cell voltage clamp experiments using single cells of the rat mesenteric artery, ADM (10(-11)-10(-7) M) as well as CGRP (10(-11)-10(-7) M) produced increases of inward current in a concentration-dependent manner. The ADM-induced current was not affected by iberiotoxin, a specific blocker of large conductance Ca2+-activated K+ channels, but suppressed markedly by glibenclamide and CGRP(8-37), a selective antagonist of CGRP1 receptors. From the results, we conclude that several naturally occurring vasodilators involving ADM synergistically interact, probably in link with K(ATP) channels, and furthermore that ADM may act, in part through CGRP1 receptor activation.
机译:为了检查天然存在的血管扩张剂之间的协同相互作用,我们研究了静脉注射的作用。输注肾上腺髓质素(ADM)并与低剂量血管活性肠多肽(VIP)或降钙素基因相关肽(CGRP)结合使用对大鼠腺苷诱导的血管抑制作用。 I.v.输注低剂量ADM(0.1 ng kg(-1)min(-1))和VIP(3 ng kg(-1)min(-1))以及ADM(1 ng kg单独(-1)min(-1)),可显着增强对推注iv的降压药反应剂量的腺苷(3-100微克kg(-1)),而不是乙酰胆碱的剂量(0.1微克kg(-1))。在格列本脲(20 mg kg(-1)i.v.)存在下,K(ATP)通道的拮抗剂没有观察到增强作用。同时进行i.v.低剂量ADM和CGRP(0.1 ng kg(-1)min(-1))的输注未能增强腺苷和乙酰胆碱的作用。在使用大鼠肠系膜动脉单细胞的全细胞电压钳实验中,ADM(10(-11)-10(-7)M)和CGRP(10(-11)-10(-7)M)产生依赖浓度的内向电流增加。 ADM诱导的电流不受埃博毒素的影响,埃博毒素是一种大传导性Ca2 +激活的K +通道的特异性阻滞剂,但被格列本脲和CGRP(8-37)(一种CGRP1受体的选择性拮抗剂)显着抑制。根据结果​​,我们得出结论,涉及ADM的几种天然血管舒张剂可能通过K(ATP)通道协同相互作用,此外,ADM可能部分通过CGRP1受体激活而起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号